AAAAAA
Results:
1-8
|
Results: 8
Authors:
Factor, SA
Molho, ES
Feustel, PJ
Brown, DL
Evans, SM
Citation: Sa. Factor et al., Long-term comparative experience with tolcapone and entacapone in advancedParkinson's disease, CLIN NEUROP, 24(5), 2001, pp. 295-299
Authors:
Factor, SA
Brown, DL
Molho, ES
Citation: Sa. Factor et al., Subcutaneous apomorphine injections as a treatment for intractable pain inParkinson's disease, MOVEMENT D, 15(1), 2000, pp. 167-169
Authors:
Factor, SA
Molho, ES
Citation: Sa. Factor et Es. Molho, Emergency department presentations of patients with Parkinson's disease, AM J EMER M, 18(2), 2000, pp. 209-215
Authors:
Hauser, RA
Friedlander, J
Zesiewicz, TA
Adler, CH
Seeberger, LC
O'Brien, CF
Molho, ES
Factor, SA
Citation: Ra. Hauser et al., A home diary to assess functional status in patients with Parkinson's disease with motor fluctuations and dyskinesia, CLIN NEUROP, 23(2), 2000, pp. 75-81
Authors:
Molho, ES
Factor, SA
Citation: Es. Molho et Sa. Factor, Worsening of motor features of Parkinsonism with olanzapine, MOVEMENT D, 14(6), 1999, pp. 1014-1016
Authors:
Molho, ES
Factor, SA
Citation: Es. Molho et Sa. Factor, Possible tardive dystonia resulting from clozapine therapy, MOVEMENT D, 14(5), 1999, pp. 873-874
Authors:
Factor, SA
Molho, ES
Citation: Sa. Factor et Es. Molho, Transient benefit of amantadine in Parkinson's disease: The facts about the myth, MOVEMENT D, 14(3), 1999, pp. 515-517
Authors:
Factor, SA
Molho, ES
Brown, DL
Citation: Sa. Factor et al., Acute delirium after withdrawal of amantadine in Parkinson's disease - Reply, NEUROLOGY, 52(8), 1999, pp. 1720-1721
Risultati:
1-8
|